PRESS-RELEASE ·Filed Jun 4, 2026

SNDX

Syndax Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago WireGlobeNewswire
Press release: activist
Actionable Insight • Neutral

Routine inducement grants have no near-term trading implications. Monitor for any future updates on employee retention or material changes in insider ownership.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
SNDX ▲ +11.25% at T+60d
NEUTRAL call ✓ call won +11.25% · α vs SPY +7.25% · entry $17.34 → $19.29
Entry anchored
Jun 4, 03:59 PM ET
via exchange tick
T+1d
-2.19%
call -2.19% · α -2.42%
$16.96
settled 4mo ago
T+5d
+5.25%
call +5.25% · α +4.68%
$18.25
settled 4mo ago
T+20d
+27.34%
call +27.34% · α +25.47%
$22.08
settled 3mo ago
T+60d
+11.25%
call +11.25% · α +7.25%
$19.29
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Syndax Pharmaceuticals granted inducement awards for 66,700 shares to four new employees under the 2023 Inducement Plan. The stock options vest over four years with a one-year cliff. This is a routine compensation event with no material impact on the company's financials or operations.

Key Facts

  • Inducement awards granted on June 1, 2026
  • 66,700 shares of common stock awarded to four new employees
  • Options vest over four years with 25% after one year and monthly thereafter

Financial Impact

Minimal; 66,700 shares represent less than 0.1% of outstanding shares based on market cap of $1.6B

dilution

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3307077
9 reports for SNDX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SNDX — sortable, filterable
TypeNow
Jul 14, 2026
11w ago
8-K
BULLISH ★ 7/10
$24.13 $20.29▼ −15.91%▼ −18.41%$17.60 (−27.06%)
Jul 1, 2026
13w ago
Press Release
NEUTRAL ★ 2/10
$21.82 $19.48▼ −10.72%▼ −10.31%$17.60 (−19.34%)
Jun 11, 2026
16w ago
Press Release
BULLISH ★ 7/10
$17.91 $24.84▲ +38.69%▲ +36.80%$17.60 (−1.73%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$17.91 $24.84▲ +38.69%▲ +36.80%$17.60 (−1.73%)
Jun 4, 2026
17w ago
Press Release
NEUTRAL ★ 2/10
$17.34 $22.08▲ +27.34%▲ +25.47%$17.60 (+1.50%)
Jun 4, 2026
17w ago
DEFA14A
NEUTRAL ★ 4/10
$18.02 $21.82▲ +21.09%▲ +22.46%$17.60 (−2.33%)
Jun 4, 2026
17w ago
8-K
NEUTRAL ★ 5/10
$18.02 $21.82▲ +21.09%▲ +22.46%$17.60 (−2.33%)
Apr 30, 2026
22w ago
DEFA14A
NEUTRAL ★ 3/10
$19.11 $18.85▼ −1.36%▼ −6.64%$17.60 (−7.90%)
Apr 24, 2026
23w ago
Press Release
NEUTRAL ★ 3/10
$21.39 $19.77▼ −7.57%▼ −11.60%$17.60 (−17.72%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (38h 31m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 4, 2026